Niklas Rye Jørgensen
Research Center for Ageing and Osteoporosis
Departments of Medicine and Clinical Biochemistry
Copenhagen University Hospital Glostrup
Nordre Ringvej 69
Denmark
Name/email consistency: high
- Effects of Anti-osteoporosis Medications on Fracture Healing. Jørgensen, N.R., Schwarz, P. Curr. Osteoporos. Rep (2011)
- Osteoporosis in chronic obstructive pulmonary disease patients. Jørgensen, N.R., Schwarz, P. Curr. Opin. Pulm. Med (2008)
- The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Jørgensen, N.R., Schwarz, P., Holme, I., Henriksen, B.M., Petersen, L.J., Backer, V. Respir. Med (2007)
- The antiarrhythmic peptide analog rotigaptide (ZP123) stimulates gap junction intercellular communication in human osteoblasts and prevents decrease in femoral trabecular bone strength in ovariectomized rats. Jørgensen, N.R., Teilmann, S.C., Henriksen, Z., Meier, E., Hansen, S.S., Jensen, J.E., Sørensen, O.H., Petersen, J.S. Endocrinology (2005)
- Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Jørgensen, N.R., Henriksen, Z., Sørensen, O.H., Civitelli, R. Steroids (2004)
- Activation of L-type calcium channels is required for gap junction-mediated intercellular calcium signaling in osteoblastic cells. Jørgensen, N.R., Teilmann, S.C., Henriksen, Z., Civitelli, R., Sørensen, O.H., Steinberg, T.H. J. Biol. Chem. (2003)
- Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors. Jørgensen, N.R., Henriksen, Z., Sørensen, O.H., Eriksen, E.F., Civitelli, R., Steinberg, T.H. J. Biol. Chem. (2002)